Feil Family Brain & Mind Research Institute

Publications

Found 803 results
[ Author(Asc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
K
Ke YD, van Hummel A, Au C, Chan G, Lee WSiang, van der Hoven J, Przybyla M, Deng Y, Sabale M, Morey N et al..  2024.  Targeting 14-3-3θ-mediated TDP-43 pathology in amyotrophic lateral sclerosis and frontotemporal dementia mice.. Neuron.
Kawamata H, Peixoto P, Konrad C, Palomo G, Bredvik K, Gerges M, Valsecchi F, Petrucelli L, Ravits JM, Starkov A et al..  2017.  Mutant TDP-43 does not impair mitochondrial bioenergetics in vitro and in vivo.. Mol Neurodegener. 12(1):37.
Kawamata H, Manfredi G.  2017.  Proteinopathies and OXPHOS dysfunction in neurodegenerative diseases.. J Cell Biol. 216(12):3917-3929.
Kauwe G, Pareja-Navarro KA, Yao L, Chen JH, Wong I, Saloner R, Cifuentes H, Nana AL, Shah S, Li Y et al..  2024.  KIBRA repairs synaptic plasticity and promotes resilience to tauopathy-related memory loss.. J Clin Invest. 134(3)
Kauwe G, Pareja-Navarro KA, Yao L, Chen JH, Wong I, Saloner R, Cifuentes H, Nana AL, Shah S, Li Y et al..  2023.  KIBRA repairs synaptic plasticity and promotes resilience to tauopathy-related memory loss.. bioRxiv.
Kaunzner UW, Kang Y, Monohan E, Kothari PJ, Nealon N, Perumal J, Vartanian T, Kuceyeski A, Vallabhajosula S, P Mozley D et al..  2017.  Reduction of PK11195 uptake observed in multiple sclerosis lesions after natalizumab initiation.. Mult Scler Relat Disord. 15:27-33.
Kaunzner UW, Kumar G, Askin G, Gauthier SA, Nealon NN, Vartanian T, Perumal JS.  2016.  A study of patients with aggressive multiple sclerosis at disease onset.. Neuropsychiatr Dis Treat. 12:1907-12.
Kang Y, Jamison K, Jaywant A, Dams-O'Connor K, Kim N, Karakatsanis NA, Butler T, Schiff ND, Kuceyeski A, Shah SA.  2022.  Longitudinal alterations in gamma-aminobutyric acid (GABAA) receptor availability over ∼ 1 year following traumatic brain injury.. Brain Commun. 4(4):fcac159.
Kamel H, Roman MJ, Pitcher A, Devereux RB.  2016.  Pregnancy and the Risk of Aortic Dissection or Rupture: A Cohort-Crossover Analysis.. Circulation. 134(7):527-33.
Kamel H, Navi BB, Sriram N, Hovsepian DA, Devereux RB, Elkind MSV.  2014.  Risk of a thrombotic event after the 6-week postpartum period.. N Engl J Med. 370(14):1307-15.
Kamel H, Healey JS.  2017.  Cardioembolic Stroke.. Circ Res. 120(3):514-526.
Kamel H, Longstreth WT, Tirschwell DL, Kronmal RA, Broderick JP, Palesch YY, Meinzer C, Dillon C, Ewing I, Spilker JA et al..  2018.  The AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenic stroke randomized trial: Rationale and methods.. Int J Stroke. :1747493018799981.
Kamel H, Navi BB, Merkler AE, Baradaran H, Díaz I, Parikh NS, Kasner SE, Gladstone DJ, Iadecola C, Gupta A.  2019.  Reclassification of Ischemic Stroke Etiological Subtypes on the Basis of High-Risk Nonstenosing Carotid Plaque.. Stroke. :STROKEAHA119027970.
Kamel H.  2017.  Evidence-Based Management of Patent Foramen Ovale in Patients With Ischemic Stroke.. JAMA Neurol.
Kamel H.  2017.  Response by Kamel to Letter Regarding Article, "Pregnancy and the Risk of Aortic Dissection or Rupture: A Cohort-Crossover Analysis".. Circulation. 135(12):e782.
Kamel H, Bartz TM, Elkind MSV, Okin PM, Thacker EL, Patton KK, Stein PK, deFilippi CR, Gottesman RF, Heckbert SR et al..  2018.  Atrial Cardiopathy and the Risk of Ischemic Stroke in the CHS (Cardiovascular Health Study).. Stroke.
Kamel H, Gialdini G, Baradaran H, Giambrone AE, Navi BB, Lerario MP, Min JK, Iadecola C, Gupta A.  2017.  Cryptogenic Stroke and Nonstenosing Intracranial Calcified Atherosclerosis.. J Stroke Cerebrovasc Dis. 26(4):863-870.
Kamel H.  2019.  Does Left Atrial Mechanical Dysfunction Contribute to a Thrombogenic Atrial Myopathy? JACC Cardiovasc Imaging.
Kamel H, Merkler AE, Iadecola C, Gupta A, Navi BB.  2019.  Tailoring the Approach to Embolic Stroke of Undetermined Source: A Review.. JAMA Neurol.
Kamel H, Chung CD, Kone GJ, Gupta A, Morris NA, Fink ME, Navi BB.  2018.  Medical Specialties of Clinicians Providing Mechanical Thrombectomy to Patients With Acute Ischemic Stroke in the United States.. JAMA Neurol.
Kamel H, Hunter M, Moon YP, Yaghi S, Cheung K, Di Tullio MR, Okin PM, Sacco RL, Soliman EZ, Elkind MSV.  2015.  Electrocardiographic Left Atrial Abnormality and Risk of Stroke: Northern Manhattan Study.. Stroke. 46(11):3208-12.
Kamel H.  2018.  Additional Factors in Considering Patent Foramen Ovale Closure to Prevent Recurrent Ischemic Stroke-Reply.. JAMA Neurol.
Kahles T, Poon C, Qian L, Palfini V, Srinivasan SPriya, Swaminathan S, Blanco I, Rodney-Sandy R, Iadecola C, Zhou P et al..  2020.  Elevated post-ischemic ubiquitination results from suppression of deubiquitinase activity and not proteasome inhibition.. Cell Mol Life Sci.
Kahl A, Blanco I, Jackman K, Baskar J, Mohan HMilaganur, Rodney-Sandy R, Zhang S, Iadecola C, Hochrainer K.  2018.  Publisher Correction: Cerebral ischemia induces the aggregation of proteins linked to neurodegenerative diseases.. Sci Rep. 8(1):6802.
Kahl A, Blanco I, Jackman K, Baskar J, Mohan HMilaganur, Rodney-Sandy R, Zhang S, Iadecola C, Hochrainer K.  2018.  Cerebral ischemia induces the aggregation of proteins linked to neurodegenerative diseases.. Sci Rep. 8(1):2701.